Johnson Investment Counsel’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.94M | Sell |
5,866
-132
| -2% | -$63.4K | 0.02% | 258 |
|
|
2026
Q1 | $2.95M | Sell |
5,998
-567
| -9% | -$308K | 0.02% | 256 |
|
|
2025
Q4 | $3.8M | Sell |
6,565
-1,111
| -14% | -$628K | 0.03% | 192 |
|
|
2025
Q3 | $3.72M | Sell |
7,676
-271
| -3% | -$126K | 0.03% | 197 |
|
|
2025
Q2 | $3.22M | Buy |
7,947
+27
| +0.3% | +$11.3K | 0.03% | 212 |
|
|
2025
Q1 | $3.94M | Sell |
7,920
-1,111
| -12% | -$602K | 0.04% | 191 |
|
|
2024
Q4 | $4.7M | Sell |
9,031
-164
| -2% | -$90.2K | 0.05% | 167 |
|
|
2024
Q3 | $5.69M | Sell |
9,195
-164
| -2% | -$97.1K | 0.06% | 153 |
|
|
2024
Q2 | $5.18M | Buy |
9,359
+309
| +3% | +$177K | 0.05% | 151 |
|
|
2024
Q1 | $5.26M | Buy |
9,050
+206
| +2% | +$116K | 0.06% | 157 |
|
|
2023
Q4 | $4.69M | Buy |
8,844
+45
| +0.5% | +$21.8K | 0.06% | 161 |
|
|
2023
Q3 | $4.45M | Buy |
8,799
+566
| +7% | +$302K | 0.06% | 155 |
|
|
2023
Q2 | $4.3M | Buy |
8,233
+105
| +1% | +$56.7K | 0.05% | 159 |
|
|
2023
Q1 | $4.68M | Buy |
8,128
+1,171
| +17% | +$660K | 0.06% | 149 |
|
|
2022
Q4 | $3.83M | Buy |
6,957
+309
| +5% | +$164K | 0.05% | 162 |
|
|
2022
Q3 | $3.37M | Buy |
6,648
+163
| +3% | +$91.2K | 0.05% | 162 |
|
|
2022
Q2 | $3.52M | Buy |
6,485
+88
| +1% | +$48.4K | 0.05% | 162 |
|
|
2022
Q1 | $3.78M | Buy |
6,397
+207
| +3% | +$119K | 0.05% | 167 |
|
|
2021
Q4 | $4.13M | Buy |
6,190
+516
| +9% | +$322K | 0.05% | 157 |
|
|
2021
Q3 | $3.24M | Buy |
5,674
+282
| +5% | +$155K | 0.04% | 171 |
|
|
2021
Q2 | $2.72M | Buy |
5,392
+1,769
| +49% | +$835K | 0.04% | 180 |
|
|
2021
Q1 | $1.65M | Hold |
3,623
| – | – | 0.02% | 247 |
|
|
2020
Q4 | $1.69M | Buy |
3,623
+150
| +4% | +$70.3K | 0.03% | 218 |
|
|
2020
Q3 | $1.53M | Buy |
3,473
+87
| +3% | +$35.9K | 0.03% | 214 |
|
|
2020
Q2 | $1.23M | Sell |
3,386
-190
| -5% | -$63.7K | 0.02% | 234 |
|
|
2020
Q1 | $1.01M | Sell |
3,576
-482
| -12% | -$152K | 0.02% | 248 |
|
|
2019
Q4 | $1.32M | Buy |
4,058
+161
| +4% | +$48.8K | 0.02% | 260 |
|
|
2019
Q3 | $1.14M | Sell |
3,897
-1,231
| -24% | -$353K | 0.02% | 271 |
|
|
2019
Q2 | $1.5M | Sell |
5,128
-9
| -0.2% | -$2.48K | 0.03% | 238 |
|
|
2019
Q1 | $1.41M | Sell |
5,137
-75
| -1% | -$18.7K | 0.03% | 251 |
|
|
2018
Q4 | $1.17M | Sell |
5,212
-446
| -8% | -$105K | 0.03% | 263 |
|
|
2018
Q3 | $1.38M | Buy |
5,658
+6
| +0.1% | +$1.38K | 0.03% | 264 |
|
|
2018
Q2 | $1.17M | Buy |
5,652
+5
| +0.1% | +$1.06K | 0.03% | 279 |
|
|
2018
Q1 | $1.17M | Sell |
5,647
-55
| -1% | -$11.5K | 0.03% | 250 |
|
|
2017
Q4 | $1.08M | Buy |
5,702
+173
| +3% | +$33.1K | 0.03% | 249 |
|
|
2017
Q3 | $1.05M | Sell |
5,529
-245
| -4% | -$44.4K | 0.03% | 252 |
|
|
2017
Q2 | $1.01M | Buy |
5,774
+345
| +6% | +$57.9K | 0.03% | 248 |
|
|
2017
Q1 | $833K | Sell |
5,429
-8
| -0.1% | -$1.22K | 0.02% | 271 |
|
|
2016
Q4 | $767K | Sell |
5,437
-64
| -1% | -$9.44K | 0.02% | 273 |
|
|
2016
Q3 | $874K | Buy |
5,501
+52
| +1% | +$8.01K | 0.03% | 245 |
|
|
2016
Q2 | $805K | Sell |
5,449
-67
| -1% | -$9.89K | 0.03% | 253 |
|
|
2016
Q1 | $781K | Buy |
5,516
+433
| +9% | +$58K | 0.03% | 249 |
|
|
2015
Q4 | $721K | Buy |
5,083
+400
| +9% | +$53.4K | 0.03% | 263 |
|
|
2015
Q3 | $572K | Sell |
4,683
-211
| -4% | -$27.5K | 0.02% | 296 |
|
|
2015
Q2 | $635K | Buy |
4,894
+590
| +14% | +$76.9K | 0.02% | 274 |
|
|
2015
Q1 | $578K | Buy |
4,304
+1,389
| +48% | +$179K | 0.02% | 295 |
|
|
2014
Q4 | $365K | Buy |
2,915
+76
| +3% | +$9.24K | 0.01% | 400 |
|
|
2014
Q3 | $345K | Buy |
2,839
+350
| +14% | +$42.6K | 0.01% | 404 |
|
|
2014
Q2 | $293K | Hold |
2,489
| – | – | 0.01% | 419 |
|
|
2014
Q1 | $299K | Sell |
2,489
-469
| -16% | -$55.8K | 0.01% | 408 |
|
|
2013
Q4 | $329K | Buy |
2,958
+116
| +4% | +$11.5K | 0.01% | 386 |
|
|
2013
Q3 | $261K | Sell |
2,842
-661
| -19% | -$59.8K | 0.01% | 437 |
|
|
2013
Q2 | $296K | Buy |
+3,503
| New | +$292K | 0.01% | 390 |
|
Other funds holding TMO
Johnson Investment Counsel's TMO Position: Q2 2026 in Review
Johnson Investment Counsel reduced its Thermo Fisher Scientific (TMO) stake by 2.2% in Q2 2026, selling an estimated $63.4K and leaving 5,866 shares worth $2.94M. The position accounts for 0.02% of the portfolio, ranked #258.
Johnson Investment Counsel first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.69M in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Johnson Investment Counsel held 5,866 shares of Thermo Fisher Scientific worth $2.94M as of Q2 2026.
- Johnson Investment Counsel sold 132 Thermo Fisher Scientific shares in Q2 2026, an estimated $63.4K.
- Thermo Fisher Scientific made up 0.02% of Johnson Investment Counsel's portfolio in Q2 2026, its #258 holding.
- Johnson Investment Counsel first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
- Johnson Investment Counsel's Thermo Fisher Scientific position peaked at $5.69M in Q3 2024.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Johnson Investment Counsel's 13F filing for Q2 2026, filed 23 Jul 2026.